| Primary |
| Glioblastoma |
26.7% |
| Cryptococcosis |
20.0% |
| Meningitis Cryptococcal |
20.0% |
| Disseminated Cryptococcosis |
13.3% |
| Endocarditis Candida |
13.3% |
| Meningitis |
6.7% |
|
| Coma |
9.1% |
| Drug Ineffective |
9.1% |
| Dysphagia |
9.1% |
| Dyspnoea |
9.1% |
| Medication Error |
9.1% |
| Nervous System Disorder |
9.1% |
| Neutropenic Sepsis |
9.1% |
| Renal Failure Acute |
9.1% |
| Speech Disorder |
9.1% |
| Urticaria |
9.1% |
| White Blood Cell Count Decreased |
9.1% |
|
| Secondary |
| Immunosuppression |
12.5% |
| Vulvovaginal Candidiasis |
12.5% |
| Meningitis Cryptococcal |
12.2% |
| Cryptococcosis |
8.4% |
| Meningitis |
8.0% |
| Product Used For Unknown Indication |
7.6% |
| Hiv Infection |
7.2% |
| Disseminated Cryptococcosis |
6.5% |
| Antiretroviral Therapy |
5.3% |
| Pneumonia |
3.0% |
| Cryptococcus Test Positive |
2.3% |
| Fungal Infection |
2.3% |
| Non-hodgkin's Lymphoma |
2.3% |
| Candidiasis |
1.5% |
| Encephalitis |
1.5% |
| Endocarditis Candida |
1.5% |
| Pemphigus |
1.5% |
| Premedication |
1.5% |
| Anaplastic Astrocytoma |
1.1% |
| Antifungal Prophylaxis |
1.1% |
|
| Multiple-drug Resistance |
21.8% |
| Renal Impairment |
12.7% |
| Immune Reconstitution Syndrome |
7.3% |
| Drug Resistance |
5.5% |
| Hyponatraemia |
5.5% |
| Urticaria |
5.5% |
| Brain Herniation |
3.6% |
| Death |
3.6% |
| Headache |
3.6% |
| Loss Of Consciousness |
3.6% |
| Medication Error |
3.6% |
| Meningitis |
3.6% |
| Pulmonary Embolism |
3.6% |
| Renal Cell Carcinoma Stage Unspecified |
3.6% |
| Thrombophlebitis |
3.6% |
| Aspartate Aminotransferase Increased |
1.8% |
| Blood Glucose Decreased |
1.8% |
| Cryptococcosis |
1.8% |
| Cryptococcus Test Positive |
1.8% |
| Csf Protein Increased |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.9% |
| Drug Use For Unknown Indication |
19.0% |
| Meningitis Cryptococcal |
10.6% |
| Hiv Infection |
8.9% |
| Rhabdomyosarcoma |
5.4% |
| Candidiasis |
3.7% |
| Encephalitis |
3.0% |
| Prophylaxis |
3.0% |
| Cryptococcosis |
2.7% |
| Mycobacterial Infection |
2.7% |
| Bronchopulmonary Aspergillosis |
2.0% |
| Candida Infection |
1.5% |
| Pustular Psoriasis |
1.5% |
| Neurocryptococcosis |
1.2% |
| Pneumonia Cryptococcal |
1.2% |
| Disseminated Cryptococcosis |
1.0% |
| Headache |
1.0% |
| Heart Transplant |
1.0% |
| Laboratory Test Abnormal |
1.0% |
| Acquired Immunodeficiency Syndrome |
0.7% |
|
| Drug Ineffective |
13.0% |
| Pneumonitis |
7.4% |
| Renal Failure Acute |
7.4% |
| Uveitis |
7.4% |
| Immune Reconstitution Syndrome |
5.6% |
| Muscular Weakness |
5.6% |
| Pyrexia |
5.6% |
| Renal Impairment |
5.6% |
| Convulsion |
3.7% |
| Hypotension |
3.7% |
| Meningitis Cryptococcal |
3.7% |
| Neutropenia |
3.7% |
| Photosensitivity Reaction |
3.7% |
| Pulmonary Oedema |
3.7% |
| Respiratory Failure |
3.7% |
| Stridor |
3.7% |
| Tachycardia |
3.7% |
| Urinary Incontinence |
3.7% |
| Vomiting |
3.7% |
| Arthritis Bacterial |
1.9% |
|
